Sun Q, Zou XI, Zhang T, Shen J, Yin Y, Xiang J
Sinai Hospital and the University of Toronto in Toronto, Canada, is being recognized for having made seminal contributions to our understanding of the physiology and pharmacology of glucagon-like peptides (GLPs) and their use for the benefit of patients. His discoveries of GLP-1, GLP-2, and dipeptidyl peptidase-4 (DPP-4) activity have enabled the development of multiple new innovative classes of medications for the treatment of diabetes, obesity, and obesity-associated comorbidities
A.RabieM
Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) -Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis